CN1498620A - Compsn. containing oligose - Google Patents

Compsn. containing oligose Download PDF

Info

Publication number
CN1498620A
CN1498620A CNA021356904A CN02135690A CN1498620A CN 1498620 A CN1498620 A CN 1498620A CN A021356904 A CNA021356904 A CN A021356904A CN 02135690 A CN02135690 A CN 02135690A CN 1498620 A CN1498620 A CN 1498620A
Authority
CN
China
Prior art keywords
oligosaccharide
dha
trace
composition according
described compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA021356904A
Other languages
Chinese (zh)
Inventor
刘亚平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA021356904A priority Critical patent/CN1498620A/en
Publication of CN1498620A publication Critical patent/CN1498620A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

An oligose composition for promoting the growth of useful bacteria in human body and taking care of brain health contains oligose, DHA (docosahexaenoic acid), and useful substances.

Description

A kind of oligosaccharide composition that contains
Technical field
The present invention relates to a kind of can make intestinal flora be improved as in shape, show the functional nutrient material of whole intestinal effect effectively.
Background technology
A large amount of studies show that human microorganism and people's health status has confidential relation, and in recent years, people begin to pay attention to the research to the little ecology of human body, and is used for prevention, treatment and the health care of disease.
Living about 100 kinds in people's the intestinal, the microorganism more than 100,000,000, they form the intestinal flora.In the intestinal bacterium, it is useful to health so promptly to resemble bifidobacterium, also has to generate the antibacterial that the disadvantageous generation of human body corruption, carcinogen etc. is unfavorable for health.The distribution of these bacteriofloras is because of the age, ethnic group, and living environment, various factors such as composition of food and changing, particularly intestinal flora is subjected to appreciable impact because of daily food is different.
Known bifidus bacillus is one of dominant bacteria in the human body intestinal canal flora, it also is the flora of neonate intestinal field planting the earliest, its major function is: 1, diarrhea and anti-constipation, its physiological action is to keep good intestinal flora state now by hindering outer field planting of attacking bacterium or pathogen, not only treats diarrhoea but also the anti-two-ways regulation function that treats constipation thereby present; 2, anti-infectious function; 3, immunomodulating and antitumor; 4, synthetic vitamin and decomposition putrefaction can embody the effect of nutrition for the catabolism of putrefaction, can participate in pressing down cancer and immunoregulation effect again indirectly, also have important function to regulating lipid metabolism simultaneously; 5, blood lipid regulation.
Lactobacillus is the ancestral home flora with health care that people are familiar with the earliest.Known lactobacillus can suppress pathogen and protection intestinal flora, the acetic acid and lactic acid in suppressing metabolite, is similar to the product of antibiotics class material in addition.After the people used antibiotic therapy in a large number, normal intestinal flora was killed in a large number, and very easily causes pseudomembranous enteritis after the over-drastic breeding of brood cell clostridium, and the bacillus acidophilus can control the excessive multiplication of this bacterium, can suppress the generation of its toxin again, thus the protection intestinal.Lactobacillus also has anticancer and immunoregulation effect, the effect of blood lipid regulation, promotion lactose metabolism.
Summary of the invention
Obviously, antibacterial for the human body beneficial in intestinal is not only above-mentioned two kinds, and keep human body micro-ecological bacterial class balance be keep fit, the key of slow down aging, other nutrient substance that purpose of the present invention will be of value to the oligosaccharide of intestinal bifidobacterium breeding and help total balance of the body combines, and promotes the breeding of human body beneficial bacterium also to provide sufficient nutrient.
Oligosaccharide has particular structure, not by gastral gastric acid and enzymic digestion, and through large intestine, by human body beneficial's flora-bifidus bacillus utilization, stimulate bifidus bacillus to breed more than 10 times, and bifidus bacillus have whole intestinal effect, it can promote intestinal peristalsis promoting, changes the stool character, the constipation of control custom.Oligosaccharide promotes human body bifidus bacillus propagation, enteral Salmonella and putrefaction bacteria growth promoter have effectively been suppressed, reduce the generation accumulation of the carcinogenic toxic metabolite of enteral, promote the drainage of toxic waste, recover the intestinal flora balance, produce the absorption of mineral such as lactic acid solubilized enteral calcium, magnesium, ferrum owing to bacterial fermentation, improve immune function of human body.
Oligosaccharide is not assimilated by human body, is similar to a kind of water soluble dietary fiber, by intestinal bacterium fermentation, produces propanoic acid, and it is synthetic to hinder cholesterol, increases the bile output, improves serum lipids.Owing to do not decomposed after oligosaccharide enters the oral cavity by saliva, can not produce insoluble glucose and a large amount of lactic acid, can avoid decayed tooth.Oligosaccharide enters the harmonization of the stomach small intestinal and is not decomposed by digestive tract, stomach, enzyme, and extremely difficulty is absorbed by human body, can not cause obesity.
Fructose oligosaccharides is to be raw material with white sugar, utilizes the catalytic action of transfructosylase, forms in conjunction with 1-3 fructose on the fructose of sucrose molecule again.Prior art is to utilize this kind of oligosaccharide separately mostly, and does not do sufficient utilization for its synergism with other benefit materials.
Oligosaccharide composition of the present invention: mainly form with oligosaccharide, DHA (22 carbon, 6 olefin(e) acids), it is made the nutriment oligosaccharide and is generally 30-70, and DHA is 5-10, and the food prepared therefrom oligosaccharide is 1-5, and DHA is 1-3.The present invention makes up oligosaccharide and brain-strengthening material DHA, but not only can promote generation but also the brain-strengthening of human body beneficial bacterium, and suitable especially people need replenish and regulate the two class crowds that need: student and old man drink.
The specific embodiment:
The present invention releases and is suitable for hypertension, arteriosclerosis, hyperlipidemia, and the functional food of prevention senile dementia is: its prescription is oligosaccharide 50-70, DHA 5-10, lecithin 10, vitamin E trace.
The student fills a prescription with milk: milk 85-90, oligosaccharide 1-5, DHA 1, EPA trace, Semen Glycines lecithin trace, linolenic acid trace, taurine trace.
Described compositions is oligosaccharide 30-50, DHA 5-10, EPA 10, glucosamine trace, OPC (Proflavanol element) 10-30, seed oil of Herba Apii graveolentis 10-30, propolis 0-10.
Described compositions oligosaccharide 1-5, DHA 2, vitamin D trace, milk 85-90, liquid activated calcium 1-2.
Described compositions oligosaccharide 50-70, DHA 5-10, fish zamene (Squalene) 5-10,10-hydroxyl-2-decylenic acid 10-20.
Described combination oligosaccharide 50-70, DHA 5-10, melatonin 20-30, vitamin B6 trace.
Described compositions oligosaccharide 30-50, DHA 5-10, sage, Mary's grass essence (the liver benefiting is peaceful) 5-10, Herba Chelidonii 0-10, Carlina acaulis 0-10, obtain cattle flower 0-10, Radix Astragali 0-10, Herba Taraxaci 0-10, Semen Glycines lecithin 0-10.
Described compositions oligosaccharide 50-70, DHA 5-10, vitamin E trace, linolenic acid 5-10, Semen Tritici aestivi germ oil 10-20, Oleum Cocois 10-20.
Described compositions oligosaccharide 50-70, DHA 5-15, balsam pear extract 10-20, Fructus psidii guajavae immaturus extracting solution 10-20, small pumpkin extracting solution 10-20.

Claims (10)

1, a kind of oligosaccharide composition: mainly form with oligosaccharide, DHA (22 carbon, 6 olefin(e) acids), it is characterized in that it makes the nutriment oligosaccharide content and be generally 30-70, DHA is 5-10; Its food prepared therefrom oligosaccharide is 1-5, and DHA is 1-3, as basic recipe, adds other material again and makes all kinds of nutrient substance or food.
2, oligosaccharide composition according to claim 1 is characterized in that being suitable for hypertension, arteriosclerosis, hyperlipidemia, and the functional food of prevention senile dementia is oligosaccharide 50-70, DHA 5-10, lecithin 10, vitamin E trace for its prescription.
3, oligosaccharide composition according to claim 1 is characterized in that being suitable for the student and with the milk composition prescription is: milk 85-90, oligosaccharide 1-5, DHA 1, EPA trace, Semen Glycines lecithin trace, linolenic acid trace, taurine trace.
4, oligosaccharide composition according to claim 1 is characterized in that described compositions is oligosaccharide 30-50, DHA 5-10, EPA 10, glucosamine trace, the plain OPE 10-30 of Proflavanol, seed oil of Herba Apii graveolentis 10-30, propolis 0-10.
5, oligosaccharide composition according to claim 1 is characterized in that the special oligosaccharide 1-5 of described combination, DHA 2, vitamin D trace, milk 85-90, liquid activated calcium 1-2.
6, oligosaccharide composition according to claim 1 is characterized in that described compositions oligosaccharide 50-70, DHA 5-10, fish zamene (Squalene) 5-10,10-hydroxyl-2-decylenic acid 10-20.
7, oligosaccharide composition according to claim 1 is characterized in that described combination oligosaccharide 50-70, DHA 5-10, melatonin 20-30, vitamin B6 trace.
8, oligosaccharide composition according to claim 1 is characterized in that described compositions is oligosaccharide 30-50, DHA 5-10, sage, Mary's grass essence (the liver benefiting is peaceful) 5-10, Herba Chelidonii 0-10, Carlina acaulis 0-10, obtains cattle flower 0-10, Radix Astragali 0-10, Herba Taraxaci 0-10, Semen Glycines lecithin 0-10.
9, oligosaccharide composition according to claim 1 is characterized in that described compositions oligosaccharide 50-70, DHA 5-10, vitamin E trace, linolenic acid 5-10, Semen Tritici aestivi germ oil 10-20, Oleum Cocois 10-20.
10, oligosaccharide composition according to claim 1 is characterized in that described compositions oligosaccharide 50-70, DHA 5-15, balsam pear extract 10-20, Fructus psidii guajavae immaturus extracting solution 10-20, small pumpkin extracting solution 10-20.
CNA021356904A 2002-11-06 2002-11-06 Compsn. containing oligose Pending CN1498620A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA021356904A CN1498620A (en) 2002-11-06 2002-11-06 Compsn. containing oligose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA021356904A CN1498620A (en) 2002-11-06 2002-11-06 Compsn. containing oligose

Publications (1)

Publication Number Publication Date
CN1498620A true CN1498620A (en) 2004-05-26

Family

ID=34231485

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA021356904A Pending CN1498620A (en) 2002-11-06 2002-11-06 Compsn. containing oligose

Country Status (1)

Country Link
CN (1) CN1498620A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1972604B (en) * 2004-06-22 2010-06-02 努特里希亚公司 Improvement of barrier integrity in HIV patients
CN101731506B (en) * 2009-12-15 2013-01-09 白万军 Health-care food of bee glue and wood frog lecithin capsule
CN103189350A (en) * 2010-11-02 2013-07-03 公益财团法人名古屋产业科学研究所 Trans-2-decenoic acid derivative and medicament containing same
CN112137997A (en) * 2020-10-30 2020-12-29 浙江工业大学 Application of DHA in preparation of medicine for relieving dyslipidemia and anxiety caused by antibiotics
CN112843119A (en) * 2021-01-18 2021-05-28 西安自然界生物学研究有限公司 Preparation process of health liquid oral liquid for improving microvascular health

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1972604B (en) * 2004-06-22 2010-06-02 努特里希亚公司 Improvement of barrier integrity in HIV patients
CN101731506B (en) * 2009-12-15 2013-01-09 白万军 Health-care food of bee glue and wood frog lecithin capsule
CN103189350A (en) * 2010-11-02 2013-07-03 公益财团法人名古屋产业科学研究所 Trans-2-decenoic acid derivative and medicament containing same
CN103189350B (en) * 2010-11-02 2016-04-27 公益财团法人名古屋产业科学研究所 Trans-2-decylenic acid derivative and containing its medicine
CN112137997A (en) * 2020-10-30 2020-12-29 浙江工业大学 Application of DHA in preparation of medicine for relieving dyslipidemia and anxiety caused by antibiotics
CN112843119A (en) * 2021-01-18 2021-05-28 西安自然界生物学研究有限公司 Preparation process of health liquid oral liquid for improving microvascular health

Similar Documents

Publication Publication Date Title
CN109198356A (en) A kind of solid beverage and preparation method thereof with adjusting function of intestinal canal
CN102511720B (en) Stachyose infant nourishing cereal and its preparation method
CN109430407A (en) Probiotic combinations preparation
CN103404921A (en) Fruit/vegetable ferment composition and preparation method thereof
CN103988863B (en) A low calorie and high nutrition baked food with health promotion function
CN111771971A (en) Composition beneficial to regulating intestinal tract, promoting digestion and improving constipation and preparation method thereof
CN111227261A (en) Prebiotic composition and application thereof
CN107593925A (en) A kind of black soya bean black fungus soymilk and preparation method thereof
CN109315769A (en) It is a kind of for improving the composition and preparation method thereof of human body enteral environment
CN105982009A (en) Composition for regulating human body intestinal micro-ecology
CN100537774C (en) A kind of is the method for feedstock production oligofructose with molasses
CN105707378A (en) Black-highland barley coffee with effect of slimming
CN106174520A (en) A kind of logical intestinal lung moistening ferment and preparation method thereof
CN106912449B (en) Method for raising selenium-rich broiler chickens
CN101077144A (en) Fruity Noodles
CN1498620A (en) Compsn. containing oligose
CN108157640A (en) A kind of complete plain dog food formula and preparation method
CN109700031A (en) For cleaning intestinal tract, the alimentation composition of enteron aisle toxin expelling
CN101797049B (en) Nutrient eight-treasure soup formula and preparation process thereof
CN106119067A (en) A kind of corn vinegar
CN105639458A (en) Preparation method of probiotics-containing barley seedling xylitol nutritional powder
CN104222272A (en) Probiotic beverage containing entermorpha prolifera
CN100441115C (en) Food enriched with water soluble diet fiber
KR20100037309A (en) Pill type manufacturing method of health supporting food
CN104304562A (en) Banana kombucha

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication